PALAU PHARMA

Local Time
Last Revised
08.03.2010

Latest News

09.01.2010Palau Pharma, member of the Board of Directors of the European Biopharmaceutical Enterprises

06.08.2010Palau Pharma reports positive First-in-Man clinical trial results for its histamine H₄ receptor antagonist UR-63325

03.08.2010Palau Pharma unveils its new website today

02.16.2010NEOGENIUS, the alliance between Almirall, Esteve, Palau Pharma and Proteomika, is to investigate new medicines for the treatment of osteoarthritis-induced pain

Factsheets Update

Meet Us At

18September

29September

10October

ERS

18-22 September 2010

Barcelona
Spain